T cell suppression is a well established phenomenon, but the mechanisms involved are still a matter of debate. Mouse anergic T cells were shown to suppress responder T cell activation by inhibiting the antigen presenting function of DC. In the present work we studied the effects of co-culturing human anergic CD4
INTRODUCTION
T cells can transfer tolerance from a tolerant to a naïve host (Gerson, 1975; Charlton et al., 1994) a phenomenon referred to as "infectious tolerance" (Zhai and KupieWeglinski, 1999) . We have shown that human CD4 þ T cells, rendered tolerant, exert suppressive activity on responder T cells in vitro (Lombardi et al., 1994; Frasca et al., 1997) . To assess whether suppression was mediated through the APC as shown in mice (Vendetti et al., 2000) , here we analysed the susceptibility of both immature and mature human DC to suppressive signals mediated by CD4 þ T cell clones anergized with OKT3 mAb (Frasca et al., 1997) . Moreover, we followed the fate of responder cells cultured with these DC in the presence of anergic cells.
RESULTS

Anergic T Cells Exert Suppression in the Presence of both Immature and Mature DC
We have demonstrated previously that human anergic CD4 þ T cells suppress proliferation of responder T cells to EBV-B transformed B cell lines (B-LCL) presenting antigen to both cell types (Lombardi et al., 1994; Frasca et al., 1997) . Here we wanted to analyze the same phenomenon in a more physiological condition using DC as APC. Clone F17, HA307-19-specific and DRB1*1101-restricted, was in part either anergized (Frasca et al., 1997) or activated with PMA þ I. Figure 1 Fig. 3b show that DC and responder cells were killed in a significant fashion in the presence of anergic cells when all three-cell types were present in the same culture. Death was mainly mediated via CD95-CD95L. In contrast, the capacity of anergic cells to kill separately responder cells or mature DC was different. Only DC were significantly killed in this condition. We interpret this as an indication that anergic cells kill not only the APC, but also responder cells, only when the three cell types come into contact by interactions driven by antigen recognition. 
Human Anergic CD4
1 T Cells Show Defective Up-regulation of CD40L
To understand the reason for lack of maturation of immature DC and increased apoptosis of mature DC in the presence of anergic cells we measured CD40L expression by anergic cells. We looked at CD40L because tolerant T cells from mice were described to express altered level of this molecule (Bowen et al., 1995) . Moreover, it has been shown that engagement of CD40 by CD40L prevents both spontaneous and CD95-induced cell death of DC (Ludewig et al., 1995; Bjorck et al., 1997; Koppi et al., 1997) and activates immature DC, a phenomenon described as APC "conditioning" or "licensing" (Lanzavecchia, 1998) . Figure 4 shows the kinetic of CD40L expression on clone F17 following activation with PMA þ I or with DRB1*1101 þ B-LCL pulsed with HA307-19, and after anergy induction expressed as mean of fluorescence intensity (MFI) measured by FACS. T cells receiving activating stimuli significantly up-regulated CD40L, whereas anergic cells did not. To produce functional data, we activated CD40 molecules on target DC by a cross-linked anti-CD40 mAb (M.M.) and used again anergic F17 as effector in a cytotoxic assay. As an important control, we tested the capacity of PI-activated cells, unable to exert suppression in Fig. 1 , to kill DC. These cells also express CD95L (a typical activation marker, not shown) together with high amount of CD40L, unlikely anergic cells shown to be CD95L þ in the absence of CD40L up-regulation, and they should rescue DC from apoptosis. Indeed, the results in Fig. 5a confirm the expectation that the killing capacity of high CD40L-expressing activated T cells against target DC was lower than that of anergic cells (although also mainly dependent on CD95-pathway, not shown). Moreover, in the same experiment we observed inhibition of apoptosis of DC activated through CD40. This strongly supported the idea that increased death of DC, in the presence of anergic cells, was due to lack of CD40 engagement on these APC.
We reasoned that if this hypothesis was correct, we should observe suppressive phenomena in the presence not only of anergic but also activated cells when CD40 -CD40L interaction is interrupted during T-DC contact. To verify this, we pre-treated both activated and anergic cells with an antagonistic anti-CD40L mAb and repeated suppression experiments. As expected, in these conditions also activated cells could exert suppression (Fig. 5b) confirming that by disrupting CD40 -CD40L interaction protection of DC from death during cognate interaction with CD95L þ T cells was abolished. To confirm that poor CD40L expression by anergic cells was insufficient for a productive interaction with CD40 on DC we decided to look at Bcl-2 expression in DC cultured with either activated or anergic cells. CD40 engagement produces upregulation of this anti-apoptotic molecule (Bjorck et al., 1997; Koppi et al., 1997) mainly implicated in protection from spontaneous apoptosis of DC (its role in CD95-mediated apoptosis is still controversial). Following intracellular staining of DC cultured for 24 h with anergic or activated F17 (and responder F17, not shown) we found that (Fig. 6 ) anergic cells were unable to induce Bcl-2 upregulation as compared to non-anergic cells. Of note, we observed a reduction of more than 50% of spontaneous apoptosis of DC only in the presence of activated, but not anergic cells (data not shown) after 24 and 48 h of co-culture.
DISCUSSION
The principal novelty of our work is that human anergic T cells can always suppress the APC function of DC: (i) by inhibiting their maturation process (ii) by triggering apoptotic pathways in fully mature DC.
Our results reinforce the important role of CD40 as regulatory molecule of DC function and demonstrate that CD40 engagement on DC can be modulated by regulation of its natural ligand expression on helper T cells. Although DC can receive maturating stimuli from pathogens, it is well known that helper T cells exert a predominant role in the activation of these APC (a phenomenon described as licensing or conditioning, Lanzavecchia, 1998) . Therefore the induction of CD40L-defective anergic cells can be a mechanism that by impairing T cell help, eventually lead to inhibition of immunity. Moreover, since the same interaction also regulates CD95-mediated apoptotic pathways in DC (as well as spontaneous elimination of DC, Bjorck et al., 1997; Koppi et al., 1997) it is plausible that in vivo mature DC survive when encountering properly activated specific CD40L þ T cells, but die in the presence of not properly activated CD40L-defective T cells (namely anergic T cells). Of interest, DC acquire susceptibility to the active pathway of apoptosis (CD95/CD95L-mediated) after full maturation. Indeed, in our hands, DC cultured for 6 days with GM-CSF and IL-4 did not express detectable levels of CD95, but in 3 more days of culture up-regulated CD95 and became susceptible to apoptosis (M.M.). This renders DC that have reached complete maturation still sensitive to suppressive stimuli of anergic/suppressor cells that can regulate their functions at different moments of their life-span.
Another very relevant finding is that anergic cells can also determine death of responder T cells, but these latter are eliminated only if responder and anergic T cells recognize antigen on the same APC (Fig. 3b) . This ensures suppression to work as an antigen specific phenomenon. Nevertheless, it remains to be clarified if all responder cells die and, if not, what the fate is of these surviving cells. In other words, if "suppressed" cells (included T cells suppressed in the presence of immature DC) are, in turn, rendered tolerant or deleted by other means. Finally, the low amount of CD40L on anergic cells fails to induce up-regulation of an anti-apoptotic molecule such as Bcl-2 that may inhibit also spontaneous apoptotic of DC, a phenomenon that we observed following 24 -48 h of coculture (not shown in this paper). Regarding this latter point, although the mechanism of active death seems to be the most relevant for T cell suppression (we could significantly abrogate suppression by using the antagonistic anti-CD95 Ab in suppression experiments, Fig. 3a ) limitation of the half-life of DC available for primary stimulation of other helper T cells or effector cells (such as CD8 T cells) can also represent a crucial parameter in the induction of cellular immune responses (de Smedt et al., 1998; Miga et al., 2001) .
MATERIAL AND METHODS
Reagents, T Cell Lines, Clones
Peptide HA307-19 was synthesized by F-MOC chemistry (Frasca et al., 1997) . Antibodies used were: OKT3 (antihuman CD3, ATCC, Rockville, MD); antagonistic anti-CD95 (M3, Immunex, Seattle, WA); anti-mouse IgG, for cross-linking of CD40 mAb (Sigma Chemical Co., St. Louis, MO); L243 (IgG2a, anti-DR, ATCC); R-PEconjugated anti-CD154 (CD40L), (TRAP-1, BD PharMingen, San Diego, CA). FITC-conjugated hamster anti-Bcl-2 (BD PharMingen). Anti CD86, Bu63, kindly provided by Peter Beverly, London, UK. Anti-CD40L (blocking) 24-31 (Alexis, Biochemicals, Vinci-Biochem, FI, Italy). T cell clones F17, HA307-19-specific and DRB1*1101-restricted, was derived from a DRB1*0101/DRB1*1101 individual. The homozigous lymphoblastoid cell line (B-LCL) used as APC was Sweig (DRB1*1101, DQA1*0501, DQB1*0301). 
